Boston Partners’s Pure Cycle PCYO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.73M Sell
172,461
-47,341
-22% -$513K ﹤0.01% 590
2025
Q4
$2.42M Buy
219,802
+19,894
+10% +$222K ﹤0.01% 548
2025
Q3
$2.21M Buy
199,908
+12,343
+7% +$129K ﹤0.01% 549
2025
Q2
$2.01M Buy
187,565
+61,784
+49% +$641K ﹤0.01% 538
2025
Q1
$1.32M Sell
125,781
-3,049
-2% -$34.6K ﹤0.01% 536
2024
Q4
$1.63M Buy
128,830
+4
+0% +$49 ﹤0.01% 518
2024
Q3
$1.39M Sell
128,826
-11,374
-8% -$117K ﹤0.01% 563
2024
Q2
$1.34M Sell
140,200
-7,430
-5% -$70.2K ﹤0.01% 549
2024
Q1
$1.4M Sell
147,630
-6,767
-4% -$67K ﹤0.01% 537
2023
Q4
$1.62M Sell
154,397
-7,968
-5% -$79.1K ﹤0.01% 520
2023
Q3
$1.56M Sell
162,365
-24,578
-13% -$277K ﹤0.01% 512
2023
Q2
$2.06M Sell
186,943
-10,717
-5% -$106K ﹤0.01% 478
2023
Q1
$1.87M Sell
197,660
-10,619
-5% -$97.9K ﹤0.01% 471
2022
Q4
$2.18M Sell
208,279
-12,232
-6% -$114K ﹤0.01% 442
2022
Q3
$1.84M Sell
220,511
-7,106
-3% -$72.9K ﹤0.01% 455
2022
Q2
$2.4M Sell
227,617
-5,527
-2% -$59.7K ﹤0.01% 426
2022
Q1
$2.8M Sell
233,144
-2,940
-1% -$36.4K ﹤0.01% 438
2021
Q4
$3.45M Sell
236,084
-2,736
-1% -$41K ﹤0.01% 403
2021
Q3
$3.18M Buy
238,820
+7,101
+3% +$103K ﹤0.01% 410
2021
Q2
$3.2M Buy
231,719
+3,097
+1% +$44.3K ﹤0.01% 409
2021
Q1
$3.07M Buy
228,622
+625
+0.3% +$7.58K ﹤0.01% 428
2020
Q4
$2.56M Sell
227,997
-4,335
-2% -$43K ﹤0.01% 408
2020
Q3
$2.09M Sell
232,332
-19,695
-8% -$185K ﹤0.01% 418
2020
Q2
$2.32M Sell
252,027
-73,734
-23% -$721K ﹤0.01% 406
2020
Q1
$3.63M Sell
325,761
-9,924
-3% -$120K 0.01% 380
2019
Q4
$4.23M Buy
335,685
+2,962
+0.9% +$34.8K 0.01% 390
2019
Q3
$3.42M Sell
332,723
-4,017
-1% -$42.8K ﹤0.01% 412
2019
Q2
$3.57M Sell
336,740
-21,468
-6% -$215K ﹤0.01% 445
2019
Q1
$3.53M Buy
358,208
+5,062
+1% +$50.1K ﹤0.01% 455
2018
Q4
$3.51M Sell
353,146
-134
-0% -$1.36K 0.01% 458
2018
Q3
$4.08M Sell
353,280
-4,622
-1% -$50.4K ﹤0.01% 492
2018
Q2
$3.42M Sell
357,902
-56,513
-14% -$535K ﹤0.01% 544
2018
Q1
$3.92M Sell
414,415
-180,236
-30% -$1.55M ﹤0.01% 532
2017
Q4
$4.96M Sell
594,651
-87,033
-13% -$655K 0.01% 502
2017
Q3
$5.11M Buy
681,684
+87,637
+15% +$637K 0.01% 496
2017
Q2
$4.6M Sell
594,047
-10,239
-2% -$73.8K 0.01% 492
2017
Q1
$3.35M Sell
604,286
-7,065
-1% -$37.5K ﹤0.01% 574
2016
Q4
$3.36M Buy
611,351
+180,052
+42% +$944K ﹤0.01% 582
2016
Q3
$2.48M Buy
431,299
+29,656
+7% +$141K ﹤0.01% 628
2016
Q2
$1.89M Buy
401,643
+8,758
+2% +$39.9K ﹤0.01% 650
2016
Q1
$1.77M Buy
392,885
+344,491
+712% +$1.55M ﹤0.01% 635
2015
Q4
$232K Buy
+48,394
New +$237K ﹤0.01% 728

Other funds holding PCYO

Boston Partners's PCYO Position: Q1 2026 in Review

Boston Partners reduced its Pure Cycle (PCYO) stake by 22% in Q1 2026, selling an estimated $513K and leaving 172,461 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #590.

Boston Partners first reported a position in PCYO in Q4 2015 and has held it in 42 quarters since. The position peaked at $5.11M in Q3 2017. 116 funds tracked by Wall St. Rank hold PCYO as of Q1 2026.

  • Boston Partners held 172,461 shares of Pure Cycle worth $1.73M as of Q1 2026.
  • Boston Partners sold 47,341 Pure Cycle shares in Q1 2026, an estimated $513K.
  • Pure Cycle made up ﹤0.01% of Boston Partners's portfolio in Q1 2026, its #590 holding.
  • Boston Partners first reported a position in Pure Cycle in Q4 2015 and has held it in 42 quarters since.
  • Boston Partners's Pure Cycle position peaked at $5.11M in Q3 2017.
  • 116 funds tracked by Wall St. Rank held Pure Cycle as of Q1 2026.

Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.